Values are presented as number (%).
The prevalence of HBV infection in the psoriasis and control groups was 3.6% (8/224) and 2.0% (7/345), respectively. Prevalence was slightly higher in the psoriasis group than in the control group, but the difference was not significant (p=0.262).
Among the 224 patients with psoriasis, there was a male predominance. However, there was no significant difference in prevalence of HBV infection between men (7/125, 5.6%) and women (1/99, 1.0%) (p=0.080). After patients Table 2 . Association between psoriasis and hepatitis B virus infection among international studies
Study Author
Kanada et al. 8 Tsai et al. 5 Cohen et al. 9 Ahmad et al. 7 Guadagnino et al. The association between HBV infection and severity of psoriasis was not significant (p=0.182) ( Table 1) . Some previous studies have implied that patients with psoriasis have higher prevalence of HBV infection than the general population. For example, Guadagnino et al. 4 showed higher risk of HBV infection in patients with chronic psoriasis or eczema in Naples, Italy (9.8% vs.
4.3%). Prevalence of HBV was 4% to 18% in the general
Italian population, indicating an HBV-rich environment. Therefore, they considered that the virus could easily penetrate through microlesions in skin affected by psoriasis 4 .
In another report in Taiwan, patients with psoriasis were reported to have high prevalence of both hepatitis B and C 5 . Because hepatitis B and C are prevalent in the overall population of Taiwan 6 , patients with psoriasis should be tested for hepatitis, as systemic treatment may increase the detection rate of hepatitis and explain the association between psoriasis and high prevalence of hepatitis. On the other hand, recent studies in India 7 , the United States 8 , and Israel 9 revealed that psoriasis was not significantly associated with increased HBV infection ( Table 2) 4,5,7-9 .
Therefore, susceptibility to HBV infection may be different among patients with varying severity of psoriasis. This study analyzed prevalence of HBV infection in Korean patients with psoriasis or other dermatologic disease. However, there was no significant difference in the prevalence of HBV infection between the control group and the psoriasis group (odds ratio, 1.788; 95% confidence inter- Although the rate of HBV infection in Korea was 6.6% to 8.6% in the 1980s 10 , the rate decreased to 2.98% in 2010
after implementation of these programs 3, 10 .
We assessed several factors in psoriasis patients with or without HBV infection. However, sex, age at onset, family history of psoriasis, and severity of psoriasis showed no association with prevalence of HBV infection. We speculated that patients with psoriasis are susceptible to HBV or that HBV aggravates psoriasis, because both psoriasis and HBV are associated with chronic inflammation. Nonetheless, psoriasis and HBV infection showed no significant association. This study has some limitations. First, the number of patients with concurrent diagnoses of psoriasis and HBV infection was relatively small. In addition, because the HBV in all patients was inactive, we could not compare severity of psoriasis before and after treatment for HBV infection. In psoriasis treatment, viral epidemiology will become more important as use of immunosuppressant agents and biologics increases. Thus, in Korea, which has a high prevalence of HBV infection, large-scale multicenter studies on the association between psoriasis and HBV infection will be important for implementing psoriasis treatment strategies.
In conclusion, this is the first study to investigate the epidemiologic association between psoriasis and HBV infection in Korea. This study did not find a significantly high prevalence of HBV infection in patients with psoriasis. Therefore, it appears that HBV infection is not associated with psoriasis in Korea. However, a larger population-based study may help to clarify the findings of this study.
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